MARKET

ANIK

ANIK

Anika Therapeutics Inc
NASDAQ
25.26
-0.14
-0.55%
After Hours: 25.26 0 0.00% 16:01 02/27 EST
OPEN
25.53
PREV CLOSE
25.40
HIGH
25.66
LOW
24.74
VOLUME
154.68K
TURNOVER
0
52 WEEK HIGH
31.80
52 WEEK LOW
16.54
MARKET CAP
369.83M
P/E (TTM)
-15.0536
1D
5D
1M
3M
1Y
5Y
Anika Therapeutics Announces Board Chair Transition
TipRanks · 1d ago
Weekly Report: what happened at ANIK last week (0219-0223)?
Weekly Report · 1d ago
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 5d ago
Weekly Report: what happened at ANIK last week (0212-0216)?
Weekly Report · 02/19 09:10
Stoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar?
NASDAQ · 02/15 11:59
Weekly Report: what happened at ANIK last week (0205-0209)?
Weekly Report · 02/12 09:09
Weekly Report: what happened at ANIK last week (0129-0202)?
Weekly Report · 02/05 09:10
Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 44% Undervaluation?
Anika Therapeutics' estimated fair value is US$44.70 based on 2 Stage Free Cash Flow to Equity. Analyst price target for ANIK is 38% below our fair value estimate of US$25.08 share price. The company is thought to be 44% undervalued at its current price. We will use a two-stage discounted cash flow model to estimate the company's intrinsic value.
Simply Wall St · 01/30 11:17
More
About ANIK
Anika Therapeutics, Inc. is a joint preservation company. The Company is engaged in creating and delivering advancements in early intervention orthopedic care, including osteoarthritis (OA) pain management, regenerative solutions, sports medicine and Arthrosurface joint solutions. The Company is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company’s product line includes OA Pain Management, Joint Preservation and Restoration, and Non-Orthopedic. Its OA Pain Management product consists of Monovisc and Orthovisc, Cingal, and Hyvisc. Its Joint Preservation and Restoration consist of regenerative solutions, sports medicine, and Arthrosurface joint solutions. Monovisc and Orthovisc are single and multi-injection, HA-based Visco supplement products, Cingal, and Hyvis. Its Non-Orthopedic products consists of HA-based products that are marketed principally for non-orthopedic applications.

Webull offers Anika Therapeutics Inc stock information, including NASDAQ: ANIK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIK stock methods without spending real money on the virtual paper trading platform.